Aerin Medical
16
0
2
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
77%
10 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.
Role: lead
A Prospective Study Comparing VivAer to Alternative Surgical Procedures to Treat Nasal Airway Obstruction in Patients With Nasal Valve Dysfunction.
Role: lead
A Study of RhinAer Stylus for Treating Chronic Rhinitis
Role: lead
An Ambispective Registry Study Comparing Clinical Outcomes of Surgical Interventions for the Treatment of Nasal Airway Obstruction.
Role: lead
Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study
Role: lead
A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)
Role: lead
The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL)
Role: lead
Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction
Role: lead
RhinAer Procedure for Treatment of Chronic Rhinitis Study
Role: lead
Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
Role: lead
Quality of Life Impact of Chronic Rhinitis Treatment With Aerin Medical Device
Role: lead
Evaluate the Effectiveness of the Vivaer ARC Stylus for Nasal Breathing
Role: collaborator
Posterior Nasal Nerve (PNN) Rhinitis Study
Role: lead
Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction
Role: lead
Treatment of Nasal Airway Obstruction Using the Aerin Medical Device
Role: lead
InFlux System for Nasal Breathing Improvement
Role: lead
All 16 trials loaded